Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fuzheng Jiedu Granules (扶正解毒颗粒) is a traditional Chinese medicine (TCM) granule preparation. It is composed of multiple herbal ingredients, commonly including but not limited to honeysuckle flower (金银花), isatis root (板蓝根), bitter apricot kernel (苦杏仁), red peony root (赤芍), and others, with formulations varying by manufacturer and indication[4]. The product is designed to support the body’s resistance (“Fu Zheng”) and detoxification (“Jie Du”), primarily used for acute upper respiratory tract infections presenting as wind-heat syndrome with deficiency in TCM terms[1][4]. The mechanism of action involves multi-component synergy from its herbal constituents, which may include anti-inflammatory, antiviral, immunomodulatory, and detoxifying effects based on TCM theory. Clinical trials have evaluated its efficacy and safety for acute upper respiratory tract infection in adults[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on fuzheng jiedu granules.